Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wallace Pharmaceuticals

Division of Mylan NV
www.wallacelaboratories.com

Latest From Wallace Pharmaceuticals

India’s Deal Street Revs Up Targeting Brands, Medical Devices, Contract Manufacturing

While the overall Indian pharmaceutical market is seeing early signs of a rebound after a dull 2013, interest is steadily building for buyout targets like high yield brands, medical devices and companies that bring expertise to manufacturing.

BioPharmaceutical Consumer

India’s Deal Street Revs Up Targeting Brands, Medical Devices, Contract Manufacturing

While the overall Indian pharmaceutical market is seeing early signs of a rebound after a dull 2013, interest is steadily building for buyout targets like high yield brands, medical devices and companies that bring expertise to manufacturing.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Wallace Laboratories
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • Richard Krukowski, SVP, Fin.
    James Costin, PhD, VP, R&D
    Paul R Edick, Corp. SVP & Pres.
  • Contact Info
  • Wallace Pharmaceuticals
    Phone: (609) 655-6000
    Half Acre Rd.
    P.O. Box 1001 Cranbury, NJ 08512
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register